Per-Johan Jakobsson

Predictive biomarkers for precision treatment in rheumatoid arthritis: are we there yet?

Rheumatoid arthritis (RA) is a chronic autoimmune disease affecting approximately 1% of the global population and is associated with a substantial reduction in both life expectancy and quality of life. Although current treatments, primarily disease-modifying antirheumatic drugs, have been shown to suppress inflammation...